ArticleFrontiers in neurology2022

Once-daily tasimelteon (VEC-162) for jet lag following transmeridian travel: A multicenter, randomized, double-blind, placebo-controlled trial.

Christos M Polymeropoulos et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.